The rise of Viagra initially drove a surge for pharma, however recent changes present a complicated outlook for investors. Generic versions are eating into revenue, and continued legal battles add more complexity to https://lilianfmqs133906.blog-mall.com/41993482/the-blue-pill-and-the-pharmaceutical-industry-a-risky-bet